Stefan Meuer

Title: The Innovative Contributions of Stefan Meuer

Introduction

Stefan Meuer is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of immunology through his innovative patents. With a total of 3 patents, his work focuses on developing novel therapeutic approaches for diseases related to the immune system.

Latest Patents

One of his latest patents is titled "Nucleic acid molecules encoding PP32: a newly identified CD45-associated protein." This invention relates to a newly identified protein that is useful for treating diseases of the immune system. It includes methods for obtaining the protein, isolated nucleic acids encoding the protein, and methods for obtaining inhibitors of the protein. The protein is characterized by an apparent molecular weight of about 32 kD, an isoelectric point of about 4.0-4.5, and coprecipitation with CD45. Additionally, this protein may be utilized in in vitro or in vivo assays to identify inhibitors of T cell activation.

Another significant patent is focused on "Bispecific molecules recognizing lymphocyte antigen CD2 and tumor." This invention relates to novel and highly effective bispecific antibody fragments that recognize the lymphocyte CD2 antigen and any variable tumor antigen. Furthermore, it introduces two new monoclonal antibodies termed AICD2.M1 and AICD2.M2. A combination of these antibodies, with at least one being a bispecific antibody fragment, can be successfully used in tumor therapy and diagnostics.

Career Highlights

Stefan Meuer has worked with prominent companies in the pharmaceutical and biotechnology sectors. Notable among these are Merck Patent Gesellschaft mit beschränkter Haftung and BASF Aktiengesellschaft. His experience in these organizations has contributed to his expertise in developing innovative solutions in the field of immunology.

Collaborations

Throughout his career, Stefan has collaborated with esteemed colleagues such as Burkhart Schraven and David Schoenhaut. These collaborations have further enhanced his research and development efforts in the field.

Conclusion

Stefan Meuer's contributions to immunology through his patents demonstrate his commitment to advancing medical science. His innovative work continues to pave the way for new therapeutic approaches in treating immune-related diseases.